Elsevier, The Lancet Regional Health - Western Pacific, Volume 20, March 2022
Reducing liver disease-related deaths in the Asia-Pacific: the important role of decentralised and non-specialist led hepatitis C treatment for cirrhotic patients
Identifying health conditions associated with Alzheimer's disease up to 15 years before diagnosis: an agnostic study of French and British health records
The Lancet Digital Health, Volume 4, March 2022
An article on Alzheimer's disease risk, in the context of SDG 3, focusing specifically on the association between health conditions diagnosed in primary care and incident Alzheimer's disease.
Elsevier, The Lancet Global Health, Volume 10, February 2022
Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation
Background: China has the highest prevalence of hepatitis B virus (HBV) infection worldwide. Universal HBV screening might enable China to reach the WHO 2030 target of 90% diagnostics, 80% treatment, and 65% HBV-related death reduction, and eventually elimination of viral hepatitis. We evaluated the cost-effectiveness of implementing universal HBV screening in China and identified optimal screening strategies.
The rise of #climateaction in the time of the FridaysForFuture movement: A semantic network analysis
Social Networks, Volume , 2022
Distribution and pollution risk assessment of heavy metals in the surface sediment of the intertidal zones of the Yellow River Estuary, China
Marine Pollution Bulletin, Volume 174, January 2022
This paper studied the heavy metal concentrations in the study area had a temporal decreasing trend compared to previous studies, which may be due to the reduction in human activities.
Elsevier, The Lancet Regional Health - Western Pacific, Volume 18, January 2022
Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling study
Background: Hepatitis C elimination may be possible with broad uptake of direct-acting antiviral treatments (DAAs). In 2016 the Australian government committed A$1.2 billion for five years of unlimited DAAs (March 2016 to February 2021) in a risk-sharing agreement with pharmaceutical companies. We assess the impact, cost-effectiveness and net economic benefits likely to be realised from this investment.
Elsevier, Data in Brief, Volume 39, December 2021
The data in this article investigated the extent of human rights awareness in the seven States comprising the Northwest geopolitical zone of Nigeria and its relationship with the characteristics of the population in the light of limited human rights claims in the region. The data was obtained from 780 respondents using stratified and systematic random sampling techniques using with the help of a structured questionnaire.
Elsevier, Current Opinion in Behavioral Sciences, Volume 42, December 2021
Climate change cognition and education: given no silver bullet for denial, diverse information-hunks increase global warming acceptance
Climate change's particular ‘perfect storm’ problem-nature requires educators and communicators to acknowledge that a single ‘silver bullet’ intervention that eliminates ignorance and denial regarding global warming may never emerge. However, diverse kinds of information-hunks and educational initiatives do incrementally increase acceptance (and alarm) regarding climate change, thus decreasing ignorance/denial.
28th October 2021
The drive to curb carbon emissions — and remove carbon from the atmosphere to the point where society is making a “net zero” contribution to CO2 levels — is essentially a scramble to secure our future on this planet. A new report from Elsevier aims to advance the understanding of research and innovation in net zero and how it supports the drive toward a clean-energy future.